תבנית:תרופה/פרבנאר 13 - Prevenar 13

×©××× ××Â !
××ª××¨××: 29/07/2025 ××ª×§××× ××××¢× ×× ×©××××§ ××ª×¨××¤× ×××¤×¡×§ ××¦×××ª××ª.

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	×¤×¨×× ××¨ - Prevenar ×¤×¨×× ××¨ 20 - Prevenar 20
×§×××¦× ×¤×¨××§××××××ª (ATC4)	J07AL Pneumococcal vaccines
××¨××× ×¤×¢×× (ATC5)	Â Pneumococcal polysaccharide serotype 1 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 14 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 18C 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 19 F 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 19A 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 23F 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 3 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 4 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 5 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 6A 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 6B 4.4 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 7F 2.2 MCG / 0.5 ML âJ07AL02 Pneumococcal polysaccharide serotype 9V 2.2 MCG / 0.5 ML âJ07AL02
×¦××¨×ª ××ª×	×ª×× ×©×¨××¨× - I.M
×¦××¨×ª ××× ××	×ª×¨×××£ ××××¨×§×, SUSPENSION FOR INJECTION ××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××
××ª××××	Active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to 17 years of age.Active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in adults â¥18 years of age and the elderly
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/×¤×¨×× ××¨ 13 - Prevenar 13
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	Â ×¢××× ××¨××¤× 13.01.2021 Â ××××¨× ××¢××× 13.01.2021 ××××¨× ××¢××× 25.03.2020 ××××¨× ××¢××× ××¨××¤× 15.07.2018 ××××¨× ××¢××× ××¨××¤× 21.06.2015 (××¡×× Microsoft Word) ××××¨× ××¢××× ××¨××¤× 31.12.2013 (××¡×× Microsoft Word) ××××¨× ××¢××× 13.08.2013 (××¡×× Microsoft Word) ××××¨× ××¢××× 19.12.2012 (××¡×× Microsoft Word) ××××¨× ××¢××× 29.11.2011 (××¡×× Microsoft Word)

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 13.01.2021 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leaflet â13.01.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 13.01.2021

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¤×¨×× ××¨ 13 ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	JOHN WYETH AND BROTHER LIMITED; TRADING AS WYETH PHARMACEUTICALS, UK
×©× ××¢× ××¨××©××	PFIZER PHARMACEUTICALS ISRAEL LTD
×¨××©×××	×ª××¨×× ×××©×: 10/2009. ×¨××©××× ××ª××¨××: 05/2015
×ª××¨×× ×¢×××× ×××¨××	29/07/2025

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

××£ ××ª×¨××¤×: ×¤×¨×× ××¨ 13 - Prevenar 13

{{×ª×¨××¤×/×¤×¨×× ××¨ 13 - Prevenar 13}}

×:

{{×ª×¨××¤×/×¤×¨×× ××¨ 13 - Prevenar 13
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־17 בספטמבר 2025 ב־10:18

תבנית:תרופה/פרבנאר 13 - Prevenar 13

ויקיתרופות